Liver transplantation for hepatocellular carcinoma

Gastroenterology

Volumn 128, Issue 6, 2005, Pages 1752-1764

  Befeler, Alex S ^a   Hayashi, Paul H ^a   Di Bisceglie, Adrian M ^a,b  

^a Saint Louis University   (United States)

^b SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CISPLATIN; DOXORUBICIN; FLUOROURACIL;

CANCER ADJUVANT THERAPY; CANCER EPIDEMIOLOGY; CANCER STAGING; CANCER SURVIVAL; CHEMOEMBOLIZATION; HUMAN; LIVER BIOPSY; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; LIVING DONOR; PREOPERATIVE CARE; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; REVIEW; SURGICAL MORTALITY;

EID: 18844447432     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2005.03.033     Document Type: Article

References (94)

1. H. El-Serag Hepatocellular carcinoma and hepatitis C in the United States Hepatology 36 2002 S74 S83
2. H. El-Serag Epidemiology of hepatocellular carcinoma Clin Liver Dis 5 2001 87 107
3. A. Befeler, A. Di Bisceglie Hepatocellular carcinoma diagnosis and treatment Gastroenterology 122 2002 1609 1619
4. A. Befeler, J. Marrero, R. Chari, L. Roberts, N. Afdhal, D. Van Thiel, A. Di Bisceglie The epidemiology and survival of patients with hepatocellular carcinoma in the United States--a preliminary report from the Liver Cancer Network (abstr) Hepatology 38 2004 216A
5. S. Caldwell, D. Oelsner, J. Iezzoni, E. Hespenheide, E. Battle, C. Driscoll Cryptogenic cirrhosis clinical characterization and risk factors for underlying disease Hepatology 29 1999 664 669
6. E. Bugianesi, N. Leone, E. Vanni, G. Marchesini, F. Brunello, P. Carucci Expanding the natural history of nonalcoholic steatohepatitis from cryptogenic cirrhosis to hepatocellular carcinoma Gastroenterology 123 2002 134 140
7. J. Marrero, R. Fontana, G. Su, H. Conjeevaram, D. Emick, A. Lok NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States Hepatology 36 2002 1349 1354
8. A. Reid, M. Resnick, Y. Chang, N. Buerstatte, J. Weissman Disparity in use of orthotopic liver transplantation among blacks and whites Liver Transpl 10 2004 834 841
9. T. Yamada, A. De Souza, S. Finkelstein, R. Jirtle Loss of the gene encoding mannose-6-phosphate/insulin-like growth factor II receptor is an early event in liver carcinogenesis Proc Natl Acad Sci U S A 94 1997 10351 10355
10. A. De Souza, G. Hankins, M. Washington, T. Orton, R. Jirtle M6P/IGF2R gene is mutated in human hepatocellular carcinomas with loss of heterozygosity Nat Genet 11 1995 447 449
11. L. Young, M. Fernandes, T. McEvoy, S. Butterwith, C. Gutierrez, C. Carolan Epigenetic change in IGF2R is associated with fetal overgrowth after sheep embryo culture Nat Genet 27 2001 153 154
12. B. Motyka, G. Korbutt, M. Pinkoski, J. Heibein, A. Caputo, M. Hobman Mannose 6-phosphate/insulin-like growth factor II receptor is a death receptor for granzyme B during cytotoxic T cell-induced apoptosis Cell 103 2000 491 500
13. M. Roncalli, P. Bianchi, B. Bruni, L. Laghi, A. Destro, S. Di Gioia Methylation framework of cell cycle gene inhibitors in cirrhosis and associated hepatocellular carcinoma Hepatology 36 2002 427 432
14. Y. Kondo, Y. Kanai, M. Sakamoto, M. Mizokami, R. Ueda, S. Hirohashi Genetic instability and aberrant DNA methylation in chronic hepatitis and cirrhosis--a comprehensive study of loss of heterozygosity and microsatellite instability at 39 loci and DNA hypermethylation on 8 CpG islands in microdissected specimens from patients with hepatocellular carcinoma Hepatology 32 2000 970 979
15. W. Fang, Z. Piao, D. Simon, J. Sheu, S. Huang Mapping of a minimal deleted region in human hepatocellular carcinoma to 1p36.13-p36.23 and mutational analysis of the RIZ (PRDM2) gene localized to the region Genes Chromosomes Cancer 28 2000 269 275
16. K. Buetow, J. Murray, J. Israel, W. London, M. Smith, M. Kew Loss of heterozygosity suggests tumor suppressor gene responsible for primary hepatocellular carcinoma Proc Natl Acad Sci U S A 86 1989 8852 8856
17. Y. Yumoto, T. Hanafusa, H. Hada, T. Morita, S. Ooguchi, N. Shinji Loss of heterozygosity and analysis of mutation of p53 in hepatocellular carcinoma J Gastroenterol Hepatol 10 1995 179 185
18. K. McGlynn, M. Edmonson, R. Michielli, W. London, W. Lin, G. Chen A phylogenetic analysis identifies heterogeneity among hepatocellular carcinomas Hepatology 36 1995 1341 1348
19. J. Marsh, S. Finkelstein, A. Demetris, P. Swalsky, E. Sasatomi, A. Bandos, M. Subotin Genotyping of hepatocellular carcinoma in the liver transplant recipients adds predictive power for determining recurrence-free survival Liver Transpl 9 2003 664 671
20. N. Iizuka, M. Oka, H. Yamada-Okabe, M. Nishida, Y. Maeda, N. Mori, T. Takao Oligonucleotide microarray for prediction of early intrahepatic recurrence of hepatocellular carcinoma after curative resection Lancet 361 2003 923 929
21. Q. Ye, L. Qin, M. Forgues, P. He, J. Kim, A.C. Peng, R. Simon, Y. Li Predicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning Nat Med 9 2003 416 423
22. J. Lee, I. Chu, J. Heo, D. Calvisi, Z. Sun, T. Roskams, A. Durnez Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling Hepatology 40 2004 667 676
23. J. Llovet, J. Fuster, J. Bruix The Barcelona approach diagnosis, staging, and treatment of hepatocellular carcinoma Liver Transpl 10 2004 S115 S120
24. J. Llovet, J. Fuster, J. Bruix Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma resection versus transplantation Hepatology 30 1999 1434 1440
25. M. Fiorentino, A. Altimari, M. Ravaioli, E. Gruppioni, E. Gabusi, B. Corti, M. Vivarelli A predictive value of biological markers for hepatocellular carcinoma patients treated with orthotopic liver transplantation Clin Cancer Res 10 2004 1789 1795
26. S. Jonas, W. Bechstein, T. Steinmuller, M. Herrmann, C. Radke, T. Berg, U. Settmacher Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis Hepatology 33 2001 1080 1086
27. J. Marsh, I. Dvorchik, C. Bonham, S. Iwatsuki Is the pathologic TNM staging system for patients with hepatoma predictive of outcome? Cancer Lett 88 2000 538 543
28. J. Llovet, J. Bruix, J. Fuster, A. Castells, J. Garcia-Valdecasas, L. Grande, A. Franca Liver transplantation for small hepatocellular carcinoma the tumor-node-metastasis classification does not have prognostic power Hepatology 27 1998 1572 1577
29. United Network for Organ Sharing. Policy 3.6 organ distribution: allocation of livers. Revised November 19, 2004. Available at: http://www.unos.org/policiesandbylaws/policies.asp?resources=true. Accessed: April 14, 2005.
30. F. Yao, L. Ferrell, N. Bass, J. Watson, P. Bacchetti, A. Venook, N. Ascher Liver transplantation for hepatocellular carcinoma expansion of the tumor size limits does not adversely impact survival Hepatology 33 2001 1394 1403
31. F. Yao, M. Kinkhabwala, J. LaBerge, N. Bass, R. Kerlan, J. Roberts The impact of expansion of conventional tumor criteria and pre-operative loco-regional treatments on survival following liver transplantation for hepatocellular carcinoma results from two centers (abstr) Hepatology 38 2003 158A
32. J. Bruix, J. Fuster, J. Llovet Liver transplantation for hepatocellular carcinoma Foucault pendulum versus evidence-based decision Liver Transpl 9 2003 700 702
33. Y. Maddala, L. Stadheim, J. Andrews, L. Burgart, C. Rosen, W. Kremers, G. Gores Drop-out rates of patients with hepatocellular cancer listed for liver transplantation outcome with chemoembolization Liver Transpl 10 2004 449 455
34. V. Mazzaferro, E. Regalia, R. Doci, S. Andreola, A. Pulvirenti, F. Bozzetti, F. Montalto Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis N Engl J Med 334 1996 693 699
35. R. Wiesner, R. Freeman, D. Mulligan Liver transplantation for hepatocellular carcinoma the impact of the MELD allocation policy Gastroenterology 127 2004 S261 S267
36. M. Khan, C. Combs, E. Brunt, V. Lowe, M. Wolverson, H. Solomon, B. Collins Positron emission tomography scanning in the evaluation of hepatocellular carcinoma J Hepatol 32 2000 792 797
37. S. Hain, I. Fogelman Recent advances in imaging hepatocellular carcinoma: diagnosis, staging and response assessment: Functional imaging Cancer J 10 2004 121 127
38. J. Bruix, M. Sherman, J. Llovet Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference J Hepatol 35 2001 421 430
39. S. Iwatsuki, R. Gordon, B.J. Shaw, T. Starzl Role of liver transplantation in cancer therapy Ann Surg 202 1985 401 407
40. T. Ismail, L. Angrisani, B. Gunson, S. Hubscher, J. Buckels, J. Neuberger, E. Elias Primary hepatic malignancy the role of liver transplantation Br J Surg 77 1990 983 987
41. H. Bismuth, P. Majno, R. Adam Liver transplantation for hepatocellular carcinoma Semin Liver Dis 19 1999 311 328
42. R. Pichlmayr Liver transplantation in primary hepatocellular carcinoma J Hepatol 18 1993 151 153
43. K. Olthoff, J. Millis, M. Rosove, L. Goldstein, K. Ramming, R. Busuttil Is liver transplantation justified for the treatment of hepatic malignancies? Arch Surg 125 1990 1261 1266
44. G. Gores, J. Steers Progress in orthotopic liver transplantation for hepatocellular carcinoma Gastroenterology 104 1993 317 320
45. B. Koneru, A. Cassavilla, J. Bowman, S. Iwatsuki, T. Starzl Liver transplantation for malignant tumors Gastroenterol Clin North Am 17 1988 177 193
46. F. Yao, N. Bass, B. Nikolai, T. Davern, R. Kerlan, V. Wu Liver transplantation for hepatocellular carcinoma analysis of survival according to the intention-to-treat principle and dropout from the waiting list Liver Transpl 8 2002 873 883
47. Institute of Medicine Analysis of waiting times Committee on Organ Transplantation. Assessing current policies and the potential impact of the DHSS final rule 1999 National Academy Press Washington, DC 57 78
48. R. Freeman, E. Edwards Liver transplant waiting time does not correlate with waiting list mortality implications for liver allocation policy Liver Transpl 6 2000 543 552
49. Organ Procurement and Transplantation Network--HRSA Final rule with comment period Fed Regist 64 1998 16296 16338
50. M. Malinchoc, P. Kamath, F. Gordon, C. Peine, J. Rank, P. ter Borg A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts Hepatology 31 2000 864 871
51. R. Wiesner, E. Edwards, R. Freeman, A. Harper, R. Kim, P. Kamath, W. Kremeres Model for end-stage liver disease (MELD) and allocation of donor livers Gastroenterology 124 2003 91 96
52. P. Hayashi, J. Trotter, L. Forman, M. Kugelmas, T. Steinberg, P. Russ Impact of pretransplant diagnosis of hepatocellular carcinoma on cadaveric liver allocation in the era of MELD Liver Transpl 10 2004 42 48
53. R. Freeman Liver allocation for HCC a moving target Liver Transpl 10 2004 49 51
54. H. Yoo, C. Patt, J. Geschwind, P. Thuluvath The outcome of liver transplantation in patients with hepatocellular carcinoma in the United States between 1987 and 2001 5-year survival has improved significantly with time J Clin Oncol 21 2003 4329 4335
55. J. Llovet, J. Bruix Systematic review of randomized trials for unresectable hepatocellular carcinoma chemoembolization improves survival Hepatology 37 2003 429 442
56. K. Olthoff, M. Rosove, C. Shackleton, D. Imagawa, D. Farmer, P. Northcross, A. Pakrasi Adjuvant chemotherapy improves survival after liver transplantation for hepatocellular carcinoma Ann Surg 221 1995 734 743
57. M. Bassanello, A. Vitale, F. Ciarleglio, A. Brolese, G. Zanus, D. D'Amico, U. Cillo Adjuvant chemotherapy for transplanted hepatocellular carcinoma patients impact on survival or HCV recurrence timing Transplant Proc 35 2003 2991 2994
58. N. De la Revilla, J. Moreno, E. Rubio, T. de Herreros, E. Navarrete, M. Lopez, V. Turrion Usefulness of chemotherapy as prophylaxis of tumor recurrence after liver transplantation in advanced hepatocellular carcinomas Transplant Proc 35 2003 1830 1831
59. M. Stone, G. Klintmalm, D. Polter, B. Husberg, R. Mennel, M. Ramsay, E. Flemens Neoadjuvant chemotherapy and liver transplantation for hepatocellular carcinoma a pilot study in 20 patients Gastroenterology 104 1993 196 202
60. B. Carr, R. Selby, J. Madariaga Prolonged survival after liver transplantation and cancer chemotherapy for advanced hepatocellular carcinoma Transplant Proc 25 1993 1128 1129
61. D. Cherqui, P. Piedbois, J. Pierga Multimodal adjuvant treatment and liver transplantation for advanced hepatocellular carcinoma Cancer 221 1994 2721 2726
62. S. Roayaie, J. Frischer, S. Emre, T. Fishbein, P. Sheiner, M. Sung, C. Miller Long-term results from multimodal adjuvant therapy and liver transplantation for the treatment of hepatocellular carcinomas larger than 5 centimeters Ann Surg 235 2002 533 539
63. D. Harnois, J. Steers, J. Andrews, J. Rubin, H. Pitot, L. Burgart, R. Wiesner Preoperative hepatic artery chemoembolization followed by orthotopic liver transplantation for hepatocellular carcinoma Liver Transpl Surg 5 1999 192 199
64. M. Shimoda, R. Ghobrial, I. Carmody, D. Anselmo, D. Farmer, H. Yersiz, P. Chen Predictors of survival after liver transplantation for hepatocellular carcinoma associated with hepatitis C Liver Transpl 10 2004 1478 1486
65. F. Yao, N. Bass, B. Nicolai, R. Merriman, T. Davern, R. Kerlan, N. Ascher A follow-up analysis of the patterns and predictors of dropout from the waiting list for liver transplantation in patients with hepatocellular carcinoma implications for current organ policy Liver Transplantation 9 2003 684 692
66. V. Mazzaferro, C. Battiston, S. Perrone, S. Pulvirenti, E. Regalia, R. Romito, D. Sarli Radiofrequency ablation of small hepatocellular carcinoma in cirrhotic patients awaiting liver transplantation a prospective study Ann Surg 240 2004 900 909
67. I. Graziadei, K. Sandmueller, P. Waldenberger, A. Koenigsrainer, K. Nachbaur, W. Jaschke, R. Margreiter Chemoembolization followed by liver transplantation for hepatocellular carcinoma impedes tumor progression while on the waiting list and leads to excellent outcome Liver Transpl 9 2003 557 563
68. H.I. Richard, J. Silberzweig, H. Mitty, W. Lou, J. Ahn, J. Cooper Hepatic arterial complications in liver transplant recipients treated with pretransplantation chemoembolization for hepatocellular carcinoma Radiology 214 2000 775 779
69. P. Majno, R. Adam, H. Bismuth, D. Castaing, A. Ariche, J. Krissat, H. Perrin Influence of preoperative transarterial lipiodol chemoembolization on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis Ann Surg 226 1997 688 701
70. J. Trotter, M. Wachs, G. Everson, I. Kam Adult-to-adult transplantation of the right hepatic lobe from a living donor N Engl J Med 346 2002 1074 1082
71. F. Sarasin, P. Majno, J. Llovet, J. Bruix, G. Mentha, A. Hadengue Living donor liver transplantation for early hepatocellular carcinoma a life-expectancy and cost-effectiveness perspective Hepatology 33 2001 1073 1079
72. C. Lo, S. Fan, C. Liu, S. Chan, J. Wong The role and limitation of living donor liver transplantation for hepatocellular carcinoma Liver Transpl 10 2004 440 447
73. CBS News. How risky is a live liver transplant? Available at: http://www.cbsnews.com/stories/2002/11/19/earlyshow/health/main530026.shtml. November 20, 2002. Accessed: April 14, 2005.
74. M. Malago, G. Test, A. Marcos Ethical considerations and rationale of adult-to-adult living donor liver transplantation Liver Transpl 7 2001 921 927
75. Adult-to-adult living donor liver transplantation cohort study (A2ALL) Hepatology 38 2003 792
76. J. Herrero, B. Sangro, J. Quiroga, F. Pardo, M. Herraiz, J. Cienfuegos, J. Prieto Influence of tumor characteristics on the outcome of liver transplantation among patients with liver cirrhosis and hepatocellular carcinoma Liver Transpl 7 2001 631 636
77. J. Fung, W. Marsh The quandary over liver transplantation for hepatocellular carcinoma the greater sin? Liver Transpl 8 2002 775 777
78. K. Shetty, K. Timmins, C. Brensinger, E. Furth, S. Rattan, W. Sun, M. Rosen Liver transplantation for hepatocellular carcinoma validation of present selection criteria in predicting outcome Liver Transpl 10 2004 911 918
79. F. Yao, J. Roberts Applying expanded criteria to liver transplantation for hepatocellular carcinoma too much too soon, or is now the time? Liver Transpl 10 2004 919 921
80. G. Otto, U. Heuschen, W. Hofmann, G. Krumm, U. Hinz, C. Herfarth Survival and recurrence after liver transplantation versus liver resection for hepatocellular carcinoma. A retrospective analysis Ann Surg 227 1998 424 432
81. J. Yamamoto, S. Iwatsuki, T. Kosuge, I. Dvorchik, K. Shimada, J. Marsh, S. Yamasaki Should hepatomas be treated with hepatic resection or transplantation? Cancer 86 1999 1151 1158
82. H. Bismuth, L. Chiche, R. Adam, D. Castaing, T. Diamond, A. Dennison Liver resection versus transplantation for hepatocellular carcinoma in cirrhotic patients Ann Surg 218 1993 145 151
83. C. Cha, L. Ruo, Y. Fong, W. Jarnagin, J. Shia, L. Blumgart, R. DeMatteo Resection of hepatocellular carcinoma in patients otherwise eligible for transplantation Ann Surg 238 2003 315 323
84. P. Majno, F. Sarasin, G. Mentha, A. Hadengue Primary liver resection and salvage transplantation or primary liver transplantation in patients with single, small hepatocellular carcinoma and preserved liver function an outcome oriented decision analysis Hepatology 31 2003 899 906
85. J. Belghiti, A. Cortes, E. Abdalla Resection prior to liver transplantation for hepatocellular carcinoma Ann Surg 238 2003 885 893
86. R. Adam, D. Azoulay, D. Castaing, R. Eshkenazy, G. Pascal, K. Hashizume, D. Samuel Liver resection as a bridge to transplantation for hepatocellular carcinoma on cirrhosis a reasonable strategy? Ann Surg 238 2003 508 519
87. R. Poon, S. Fan, C. Lo, C. Liu, J. Wong Long term survival and pattern of recurrence after resection of small hepatocellular carcinoma in patients with preserved liver function Ann Surg 235 2002 373 382
88. M. Chirica, F. Durand, D. Sommacale, F. Dondero, C. Francoz, V. Paradis, A. Sauvanet Long term outcome after resection for small hepatocellular carcinoma (HCC) in patients with hepatitis C virus (HCV) infection arguments for a strategy of resection as a bridge to transplantation rather than salvage transplantation (abstr) Hepatology 40 2004 162A
89. M. Sala, J. Fuster, M. Navasa, M. Sole, M. Varela, F. Pons, A. Rimola High pathological risk of recurrence after surgical resection for hepatocellular carcinoma an indication for salvage liver transplantation Liver Transpl 10 2004 1294 1300
90. D. McGill, J. Rakela, A. Zinsmeister, B. Ott A 21-year experience with major hemorrhage after percutaneous liver biopsy Gastroenterology 99 1990 1396 1400
91. H. Isobe, Y. Imari, H. Sakai, S. Sakamoto, H. Nawata Subcutaneous seeding of hepatocellular carcinoma following fine-needle aspiration biopsy J Clin Gastroenterol 17 1993 350 352
92. S. Schotman, R. De Man, J. Stoker, P. Zondervan, J. Ijzermmans Subcutaneous seeding of hepatocellular carcinoma after percutaneous needle biopsy Gut 45 1999 626 627
93. A. Frilling, C. Broelsch Letters to the editor Ann Surg 235 2002 604
94. I. Levy, P. Greig, S. Gallinger Resection of hepatocellular carcinoma without preoperative biopsy Ann Surg 234 2001 206 209